Powell Lynne

CIK 00016316672 companiesDURHAM, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001631667

Recent Transactions

50 trades

Award
BIORA THERAPEUTICS, INC.
Common Stock
2024-06-05+12,500→ 30,746 total
Award
BIORA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2024-06-05+12,500→ 12,500 total
Award
BIORA THERAPEUTICS, INC.
Common Stock
2023-06-14+12,500→ 18,246 total
Award
BIORA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2023-06-14+12,500→ 12,500 total
Disposition to Issuer
BIORA THERAPEUTICS, INC.
Series X Preferred Stock
2023-01-03−45→ 0 total
Award
BIORA THERAPEUTICS, INC.
Common Stock
2022-06-15+96,154→ 143,672 total
Award
BIORA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2022-06-15+148,810→ 148,810 total
Award
BIORA THERAPEUTICS, INC.
Common Stock
2021-06-14+29,183→ 47,518 total
Award
BIORA THERAPEUTICS, INC.
Stock Option (Right to Buy)
2021-06-14+51,724→ 51,724 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-01-28−2,000→ 79,427 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-28$3.22/sh+2,000→ 2,000 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-01-28−4,000→ 81,427 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-28$9.88/sh−4,000→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-28$3.22/sh+4,000→ 4,000 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-28$9.91/sh−2,000→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-01-25−6,000→ 85,427 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-25$3.22/sh+6,000→ 6,000 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-25$9.60/sh−6,000→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-18$3.22/sh+2,000→ 2,000 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-18$9.40/sh−2,000→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-01-18−2,000→ 91,427 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-01-16−3,046→ 93,427 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-16$3.22/sh+3,046→ 3,046 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-16$9.27/sh−3,046→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-01-14−954→ 96,473 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-14$9.20/sh−954→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-01-14$3.22/sh+954→ 954 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2018-12-20+190,000→ 190,000 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2018-12-10−2,000→ 99,427 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2018-12-10−2,000→ 97,427 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-12-10$9.11/sh−2,000→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-12-10$3.22/sh+2,000→ 2,000 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-12-10$9.01/sh−2,000→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-12-10$3.22/sh+2,000→ 2,000 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-11-21$9.01/sh−2,455→ 0 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2018-11-21−12,000→ 101,427 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-11-21$9.06/sh−12,000→ 2,455 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-11-21$3.22/sh+12,000→ 14,455 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-11-20$8.61/sh−6,150→ 2,455 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-11-20$3.22/sh+9,127→ 17,732 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-11-20$8.52/sh−9,127→ 8,605 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2018-11-20−9,127→ 113,427 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2018-11-19−193→ 122,554 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-11-19$8.30/sh−193→ 8,605 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-11-19$3.22/sh+193→ 8,798 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2018-11-08−5,280→ 122,747 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-11-08$3.22/sh+5,280→ 13,885 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-11-08$8.15/sh−5,280→ 8,605 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2018-11-07−300→ 128,027 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2018-11-07$8.00/sh−300→ 8,605 total

Companies

Recent Filings

Address

4505 EMPEROR BLVD. SUITE 200

DURHAM, NC, 27703

View on SEC.gov